Nevro Corp (NYSE:NVRO) Director Elizabeth H. Weatherman Purchases 2,460 Shares

Nevro Corp (NYSE:NVRO) Director Elizabeth H. Weatherman purchased 2,460 shares of the company’s stock in a transaction on Friday, June 7th. The shares were bought at an average price of $60.99 per share, for a total transaction of $150,035.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Nevro stock opened at $62.01 on Tuesday. The company has a market capitalization of $1.85 billion, a PE ratio of -37.81 and a beta of 0.25. The company has a current ratio of 6.30, a quick ratio of 4.87 and a debt-to-equity ratio of 0.83. Nevro Corp has a fifty-two week low of $34.75 and a fifty-two week high of $86.75.

Nevro (NYSE:NVRO) last released its earnings results on Thursday, May 9th. The medical equipment provider reported ($1.45) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.79). The firm had revenue of $82.10 million during the quarter, compared to analysts’ expectations of $87.47 million. Nevro had a negative return on equity of 31.84% and a negative net margin of 19.79%. The business’s revenue was down 6.3% on a year-over-year basis. During the same period last year, the business earned ($0.59) earnings per share. On average, equities research analysts predict that Nevro Corp will post -3.83 earnings per share for the current fiscal year.



Several institutional investors have recently added to or reduced their stakes in the company. Advisor Group Inc. increased its position in shares of Nevro by 64.5% in the fourth quarter. Advisor Group Inc. now owns 921 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 361 shares in the last quarter. Parametric Portfolio Associates LLC increased its position in shares of Nevro by 1.5% in the first quarter. Parametric Portfolio Associates LLC now owns 30,595 shares of the medical equipment provider’s stock worth $1,912,000 after acquiring an additional 463 shares in the last quarter. State Board of Administration of Florida Retirement System grew its position in Nevro by 3.5% during the fourth quarter. State Board of Administration of Florida Retirement System now owns 15,679 shares of the medical equipment provider’s stock valued at $610,000 after purchasing an additional 525 shares in the last quarter. SEI Investments Co purchased a new position in Nevro during the first quarter valued at approximately $40,000. Finally, Trillium Asset Management LLC grew its position in Nevro by 8.1% during the first quarter. Trillium Asset Management LLC now owns 9,792 shares of the medical equipment provider’s stock valued at $612,000 after purchasing an additional 735 shares in the last quarter.

A number of analysts recently commented on NVRO shares. Zacks Investment Research upgraded shares of Nevro from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 14th. ValuEngine upgraded shares of Nevro from a “hold” rating to a “buy” rating in a report on Wednesday, May 15th. Wells Fargo & Co dropped their target price on shares of Nevro from $75.00 to $70.00 and set an “outperform” rating on the stock in a report on Monday, May 13th. Canaccord Genuity downgraded shares of Nevro from a “buy” rating to a “hold” rating and dropped their target price for the stock from $62.00 to $50.00 in a report on Friday, May 10th. Finally, JMP Securities dropped their target price on shares of Nevro from $80.00 to $70.00 and set a “market outperform” rating on the stock in a report on Friday, May 10th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $57.83.

ILLEGAL ACTIVITY WARNING: “Nevro Corp (NYSE:NVRO) Director Elizabeth H. Weatherman Purchases 2,460 Shares” was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://dakotafinancialnews.com/2019/06/11/nevro-corp-nysenvro-director-elizabeth-h-weatherman-purchases-2460-shares.html.

About Nevro

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain.

See Also: Recession

Receive News & Ratings for Nevro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro and related companies with MarketBeat.com's FREE daily email newsletter.